Dirk Sibbing

Dirk Sibbing

Ludwig-Maximilians-University, Munich, Germany

  • Twitter
  • Radcliffe

Articles by Dirk Sibbing

Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis

Dirk Sibbing, Michael J Blaha, Rajinder Chawla, et al

Published:

Citation: European Cardiology Review 2024;19:e01.